Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 11 July 2019, 11:00 HKT/SGT
Share:
    

Source: Novotech
Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research

SINGAPORE, July 11, 2019 - (ACN Newswire) - Novotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in skin research clinical trials.

The Partnership formalizes a long-standing working relationship between the two, enabling closer collaboration to ensure the high priority start-up of new projects, and cooperation in clinical trial promotion, business development, networking opportunities, clinical operation, training, and feasibility assessment.

SRIS was established as a collaboration between Agency for Science, Technology and Research (A*STAR), National Healthcare Group (NHG) and Nanyang Technological University (NTU) to conduct high impact, inter-disciplinary skin research that would translate into improved health outcomes and quality of life.

Novotech now has over 20 significant Partnerships with some of the leading medical institutions in the region. The Partnership Program is strategically designed to bring unparalleled access to quality investigators, KOLs, and up to 4 million patients for its international biotech clients.

Novotech CEO Dr John Moller said the Partnership with SRIS will support the increasing demand from biotech clients for skin disorder studies in the Asia-Pacific region.

Please visit the Skin Research Institute of Singapore (SRIS)at https://www.a-star.edu.sg/sris/About-SRIS.

About Novotech:
Headquartered in Sydney, Novotech CRO is the internationally recognized Asia Pacific contract research organization (CRO) instrumental in hundreds of clinical trials across the region. https://novotech-cro.com/welcome
Check if Asia Pacific is right for your next study: https://novotechcro.typeform.com/to/Uwizka
For RFP enquiries, please fill out the form available at www.novotech-cro.com/contact-us-0

Media contact:
[email protected]
Susan Fitzpatrick-Napier
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427


July 11, 2019 11:00 HKT/SGT
Topic: Press release summary
Sectors: HealthCare
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Multimedia
SuLyn Yip, Novotech Country Manager, and Dr Steven Thng, Executive Director of SRIS, signing the Partnership.
View Image
 
View Image
 

Novotech
May 31, 2019 07:00 HKT/SGT
Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO
Apr 18, 2019 04:00 HKT/SGT
Novotech CRO strengthens South Korean Clinical Capabilities, partners with 2 Major Hospitals
Mar 25, 2019 18:00 HKT/SGT
Novotech CNS USA Appoints Dr Robert Malone to its Washington, DC BioDesk
Dec 17, 2018 08:00 HKT/SGT
Novotech CRO Launches Largest Oracle Trial Management and Monitoring Cloud Service Implementation in Asia-Pacific
Nov 28, 2018 11:02 HKT/SGT
Novotech CRO Announces 41 Clinical Staff and 81 Projects in South Korea
Oct 19, 2018 07:00 HKT/SGT
Novotech and CNS deal expands CRO services for Biopharma Clients across Asia-Pacific
Aug 23, 2018 13:00 HKT/SGT
Novotech the Asia-Pacific CRO named Top 10 CRO
Aug 9, 2018 13:00 HKT/SGT
Sponsors Recommend Novotech for CRO Leadership Award
July 19, 2018 06:00 HKT/SGT
Novotech Partners with Asian Eye Institute for Accelerated Ophthalmic Drug and Devices Clinical Trials
June 28, 2018 06:00 HKT/SGT
Novotech at DIA18 announces Asia Partnerships on Target to Reach 1.4 Bil Patients
More news >>
 News Alerts
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: